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INTRODUCTION
Calcium plays essential roles in neural excitation, muscle
contraction, blood conjugation, bone formation, hormone secre-
tion, cell adhesion, and enzyme activation. Blood concentra-
tion of calcium is tightly controlled within a narrow range
by harmonious cooperation between three organs; kidney, bone,
and intestine.
The kidneys contribute to calcium homeostasis by control-
ling calcium excretion. Only unbound calcium, which is 60
% of total calcium, is filtered and most of the filtered calci-
um is reabsorbed in the proximal tubule (PT) and the thick
ascending limb (TAL) passively via paracellular pathway driv-
en by sodium and water reabsorption (1-3). Fine regulation
of calcium excretion occurs in the distal nephron, where small
fraction of filtered calcium is reabsorbed by active transcellu-
lar calcium transport. Transporters involved in this process
include transient receptor potential vanilloid 5 (TRPV5) and
transient receptor potential vanilloid 6 (TRPV6) on the lumi-
nal membrane, calbindin-D28K in the cytoplasm, and Na+-Ca2+
exchanger type 1 (NCX1) and plasma membrane Ca2+-ATP
ase (PMCA) on the basolateral membrane (4). TRPV5 has been
considered to play the most important role in active calcium
reabsorption and its coexistence with calbindin-D28K, NCX1,
and PMCA has been proved by immunohistochemistry (5).
Renal loss of calcium is one of the proposed mechanisms of
idiopathic hypercalciuria. Idiopathic hypercalciuria is char-
acterized by urinary calcium excretion of >0.1 mM/kg/day
(>4 mg/kg/day) without a definite underlying cause (6, 7).
Despite being named by Albright about 50 yr ago (8), the
pathophysiology is still unclear and diagnosis remains exclu-
sive. Proposed pathogenic mechanisms are increased intesti-
nal calcium reabsorption, increased renal loss, and augment-
ed bone resorption (9, 10).
Thiazide diuretics, which inhibit sodium-chloride cotrans-
porter (NCC) in the distal convoluted tubule, have been adopt-
ed as a treatment of choice for idiopathic hypercalciuria due
to their hypocalciuric effect (11). Although several reports de-
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Effects of Thiazide on the Expression of TRPV5, Calbindin-D28K, and
Sodium Transporters in Hypercalciuric Rats
TRPV5 is believed to play an important role in the regulation of urinary calcium excre-
tion. We assessed the effects of hydrochlorothiazide (HCTZ) on the expression of
TRPV5, calbindin-D28K, and several sodium transporters in hypercalciuric rats. Sp-
rague-Dawley rats were divided into 4 groups; control, HCTZ, high salt, and high
salt with HCTZ group in experiment 1; control, HCTZ, high calcium (Ca), and high
Ca with HCTZ group in experiment 2. To quantitate the expression of TRPV5, cal-
bindin-D28K, and sodium transporters, western blotting was performed. In both experi-
ments, HCTZ significantly decreased urinary calcium excretion. TRPV5 protein abun-
dance decreased in all hypercalciuric rats, and restored by HCTZ in both high salt
with HCTZ and high Ca with HCTZ group. Calbindin-D28K protein abundance increased
in the high salt and high salt with HCTZ groups, but did not differ among groups in
experiment 2. Protein abundance of NHE3 and NKCC2 decreased in all hypercal-
ciuric rats, and were restored by HCTZ in only high Ca-induced hypercalciuric rats.
In summary, protein abundance of TRPV5, NHE3, and NKCC2 decreased in all hyper-
calciuric rats. The hypocalciuric effect of HCTZ is associated with increased protein
abundance of TRPV5 in high salt or calcium diet-induced hypercalciuric rats.
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Accepted : 28 November 2008monstrated that thiazides increase bone mineral density and
consequently reduce the risk of fracture (12-14), the mecha-
nism of the hypocalciuric effect of thiazides and its effects on
calcium transporters in the distal convoluted tubule are still
controversial. 
The purpose of this study was to elucidate mechanisms of
the hypocalciuric effect of thiazides in high salt diet or high
calcium diet-induced hypercalciuric rats. We analyzed the
expression of TRPV5, calbindin-D28K, and sodium transporters
of the PT and TAL in hypercalciuric rats and the changes of
them after hydrochlorothiazide (HCTZ) administration.
MATERIALS AND METHODS
Experimental protocols and measurement of physiologic
variables
Forty specific pathogen-free male Sprague-Dawley rats (6
weeks, 160-180 g; SLC, Shizuoka, Japan) were placed in sep-
arate metabolic cages 3 days before the beginning of the study.
All rats were provided with fixed amount of finely ground
regular rat chow (14.7 g/200 g of body weight per day) con-
taining 0.3% (0.05 mM/g) NaCl and 1.3% (0.16 mM/g)
CaCO3. The rats were allowed free access to drinking water
containing 0.8% NaCl and 0.1% KCl. All studies were appr-
oved by the institutional board for animal research (IACUC).
Experiment 1
Twenty rats were randomly allocated to the control (N1)
group (NaCl 0.05 mM/g of chow, n=5), the HCTZ (T1) group
(NaCl 0.05 mM/g of chow & HCTZ 7 mg/day, n=5), the high
salt (S) group (NaCl 1.32 mM/g of chow, n=5), and the high
salt with HCTZ (ST) group (NaCl 1.32 mM/g of chow &
HCTZ 7 mg/day, n=5). Rats in the S and ST groups were
provided with rat chow containing 8% (1.32 mM/g) NaCl
(Sigma, St. Louis, MO, U.S.A.) of chow (14.7 g/200 g of body
weight per day). Rats in the N1 and T1 groups were given
the same amount of regular rat chow. Osmotic minipumps
(model 2ML1, Alzet, Palo Alto, CA, U.S.A.) were implant-
ed subcutaneously in the T1 and ST groups to deliver 7 mg/
day HCTZ for 7 days. HCTZ was dissolved in 1.7% ethan-
olamine. And the osmotic minipumps containing vehicle only
were implanted in the N1 and S groups. On day 7, all rats were
sacrificed after bilateral nephrectomy and blood sampling
under anesthesia using ethyl carbamate (33 g in 100 mL PBS,
0.5 cc/200 g body weight, intraperitoneal injection).
Experiment 2
Twenty rats were randomly allocated to the control (N2)
group (CaCO3 0.16 mM/g of chow, n=5), the HCTZ (T2)
group (CaCO3 0.16 mM/g of chow & HCTZ 7 mg/day, n=
5), the high Ca (calcium diet; C) group (CaCO3 0.74 mM/g
of chow, n=5), and the high Ca with HCTZ (CT) group (Ca
CO3 0.74 mM/g of chow & HCTZ 7 mg/day, n=5). Rats in
the C and CT groups were provided with rat chow contain-
ing 5% (0.74 mM/g) CaCO3 (Sigma) of chow (14.7 g/200 g
of body weight per day). Rats in the N2 and T2 groups were
given the same amount of regular rat chow. Osmotic minipumps
(model 2ML1, Alzet) were implanted subcutaneously in the
T2 and CT groups to deliver 7 mg/day HCTZ for 7 days. And
the osmotic minipumps containing only vehicle were implant-
ed in the N2 and C groups. On day 7, all rats were sacrificed
after bilateral nephrectomy and blood sampling under anes-
thesia using ethyl carbamate.
In both experiments, body weight, water intake, and urine
volume were measured daily. Urinary calcium was measured
using Automated Electrolyte Analyzer EA07S (A&T, Yoko-
hama-shi, Knagawa, Japan) and urinary creatinine was mea-
sured using Automatic Anaylzer 7170 (HITACHI, Ibaraki,
Japan) in the first and last 24-hr urine. Calcium excretion was
expressed as the calcium to creatinine ratio. Also, serum sodi-
um and calcium levels were measured using Toshiba 200FR-
1 (Toshiba, Tokyo, Japan) and hematocrit levels were measured
using Automated Hematology Analyzer XE-2100 (Sysmex,
Kobe, Japan).
Semiquantitative immunoblotting
The kidneys were dissected into small pieces and placed in
a chilled isolation buffer containing 0.3 M sucrose, 10 mM
triethanolamine (Sigma), 1 μ g/mL leupeptin (Sigma), and
0.1 mg/mL phenylmethylsulfonylfluoride (Sigma) titrated
to pH 7.6. Then the pieces were homogenized at 15,000 rpm
with three stokes for 15 sec with a tissue homogenizer (Power
Gun 125, Fisher Scientific, Pittsburgh, PA, U.S.A.). After
homogenization, total protein concentration of the homogenate
was measured by Bicinchoninic acid protein assay method
(BCA Reagent Kit; Sigma) and diluted to 2.50 μ g/mL using
the isolation buffer solution. The samples were then stabi-
lized by heating to 60℃ for 15 min after adding 1 vol 5×
Laemmli sample buffer/4 vol sample.
Initially, “loading gels” were done on each sample set to
calculate the exact loading amount that would guarantee equal
loading on subsequent immunoblots. Ten micrograms of pro-
tein from each sample were loaded into each individual lane
and electrophoresed on 12% polyacrylamide-SDS minigels
by using Mini-PROTEIN III electrophoresis apparatus (Bio-
Rad, Hercules, CA, U.S.A.) and then were stained with Co-
omassie blue dye (0.025% solution made in 4.5% methanol
and 1% acetic acid; G-250, Bio-Rad). Selected bands from
these gels were scanned with image analyzer (Vilber Lourmat,
Marne la Vallee, France) to semiquantitatively determine densi-
ty with LabWorks version 4.5 software (Ultra-Violet Products,
Cambridge, U.K.) and relative amounts of protein loaded in
each lane. Protein concentrations were corrected to reflect these
measurements by repeating the process as described above.
For semiquantitative immunoblotting, the proteins elec-
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′trophoresed on gels were transferred from unstained gels to
nitrocellulose membrane (Bio-Rad) using the electroelution
method. After being blocked with 5% skim milk in PBS-T
(80 mM Na2HPO4, 20 mM NaH2PO4, 100 mM NaCl, and
0.1% Tween-20, pH 7.5) for 30 min, membranes were probed
overnight at 4℃with the respective primary antibodies. Affin-
ity-purified immunoglobulin against TRPV5 (CHEMICON
International, Temecula, CA, U.S.A.) and affinity-purified
polyclonal antibodies for calbindin-D28K (ALPHA DIAG-
NOSTIC International, San Antonio, CA, U.S.A.) were used.
The affinity-purified polyclonal antibodies against sodium-
potassium-chloride cotransporter type 2 (NKCC2) and NCC
were provided by Dr. HM Kwon (University of Maryland,
Baltimore, MD, U.S.A.), and the antibodies against sodium-
hydrogen exchanger 3 (NHE3) were provided by Dr. MA
Knepper (NIH, Bethesda, MD, U.S.A.). Affinity-purified
polyclonal antibodies against sodium-glucose cotransporter
1 (SGLT1) (CHEMICON International) were also used. For
probing blots, all primary antibodies were diluted into a solu-
tion containing 150 mM NaCl, 50 mM sodium phosphate,
10 mg/dL sodium azide, 50 mg/dL Tween 20, and 0.1 g/dL
bovine serum albumin (pH 7.5). Then, the membranes were
cleaned with PBS-T and probed with secondary antibodies
for 1 hr at room temperature. The secondary antibody was
horseradish peroxidase-conjugated donkey anti-rabbit IgG
(31458; Pierce, Rockford, IL) diluted to 1:3,000 except for
calbindin-D28K. The secondary antibody for calbindin-D28K
was horseradish peroxidase-conjugated rabbit anti-mouse IgG
(31452; Pierce, Rockford, IL, U.S.A.) diluted to 1:5,000.
Antibody-antigen reaction sites were viewed with enhanced
chemiluminescence system (ECLTM RPN 2106; Amersham
Pharmacia Biotech, Buckinghamshire, U.K.) before expos-
ing to radiography films (Hyperfilm, Amersham Pharmacia
Biotech, Little Chalfont, U.K.). Band density was measured
by densitometry with Lab Works version 4.5 software (Ultra-
Violet Products, Cambridge, U.K.) and calculated as a value
relative to the average value of the control group.
Statistical analysis
All values are expressed as mean±standard deviation (SD).
Band density values were normalized by dividing them with
the average value of the control group. Thus the mean for the
control group was defined as 100%. Group means of physi-
ologic data were compared with ANOVA followed by New-
man-Keuls post hoc analysis using GraphPad Prism version
4 (GraphPad Software, San Diego, CA, U.S.A.). Group means
of protein abundance obtained from immunoblotting were
compared with Mann-Whitney test using SPSS 12.0K. A p-
value <0.05 was considered statistically significant.
RESULTS
Hypercalciuria induced by high salt diet
Urinary excretion of calcium
There was no significant difference in body weight, hema-
tocrit, and serum sodium concentration among groups (Table 1).
Urine Ca/Cr on day 0 was not significantly different among
groups. On day 7, urine Ca/Cr was significantly increased in
the high salt group, and decreased in the high salt with HCTZ
group when compared to the high salt group (control vs. HCTZ
vs. high salt vs. high salt with HCTZ, 0.39±0.15 vs. 0.19
±0.07 vs. 1.52±0.51 vs. 0.62±0.19; p<0.05). Urine Ca/
Cr in the high salt with HCTZ group was 41% of the level
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N1 (Control) T1 (HCTZ) S (High salt) ST (High salt with HCTZ)
Body weight gain (g) 35.00±6.78 37.00±3.70 41.60±5.13 37.80±4.32
Urine volume (mL) 10.35±3.92 21.52±3.48* 93.22±20.46* 95.95±13.88*
Serum Ca (mg/dL) 9.40±1.01 9.50±2.49 8.68±1.09 9.34±1.15
Serum Na (mM/L) 141.75±0.96 142.00±3.16 138.25±4.03 136.50±3.11
Hematocrit (%) 49.47±3.00 50.60±6.23 49.90±5.62 43.30±4.95
Values are means±SD (standard deviation).
*p<0.05 when compared to the control group.
Table 1. Body weight gain, urine volume, hematocrit, and serum sodium concentration in high salt diet-induced hypercalciuric rats (n=
5 in each group)
Fig. 1. Urine Ca/Cr ratio on day 7 in high salt diet-induced hyper-
calciuric rats. Urine Ca/Cr was significantly increased in the high
salt group, and decreased in the high salt with HCTZ group when
compared to the high salt group.
*p<0.05 when compared to the control group; 
� p<0.05 when com-
pared to the high salt group.
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�in the high salt group (Fig. 1). Urine Ca/Cr is summarized
in Table 2.
Protein abundance using semiquantitative immunoblotting
TRPV5 protein abundance was significantly increased in
the HCTZ group, decreased in the high salt group, and restored
in the high salt with HCTZ group when compared to the
high salt group (band density [%]; control vs. HCTZ vs. high
salt vs. high salt with HCTZ, 100±18.02 vs. 184.27±41.49
vs. 69.07±15.18 vs. 78.29±33.57; Fig. 2). Calbindin-D28K
protein abundance was significantly increased in the high salt
and the high salt with HCTZ groups (band density [%]; con-
trol vs. HCTZ vs. high salt vs. high salt with HCTZ, 100±
42.33 vs. 94.10±12.79 vs. 222.63±12.24 vs. 258.44±
92.26; Fig. 3). Protein abundance of NHE3, SGLT1, NKCC2,
and NCC increased in the HCTZ group, but protein abun-
dance of NHE3 and NKCC2 decreased in the high salt group
(band density: control vs. HCTZ vs. high salt vs. high salt
with HCTZ, NHE3 [%]; 100±31.83 vs. 126.59±21.68
vs. 5.36±1.13 vs. 1.33±0.69, SGLT1 [%]; 100±22.23
vs. 182.45±22.66 vs. 146.53±5.26 vs. 125.61±12.67,
NKCC2 [%]; 100±11.14 vs. 139.48±8.60 vs. 61.15±
19.89 vs. 54.56±13.73, NCC [%]; 100±4.74 vs. 133.11
±17.22 vs. 98.61±9.40 vs. 66.60±14.15; Fig. 4).
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N1 (Control) T1 (HCTZ) S (High salt) ST (High salt with HCTZ)
D0 Urine Ca/Cr 0.60±0.06 0.61±0.31 0.63±0.17 0.58±0.17
D7 Urine
Ca/Cr 0.39±0.15 0.19±0.07* 1.52±0.51* 0.62±0.19
�
FECa (%) 2.14±0.85 1.03±0.60* 8.74±2.48* 3.42±0.82*
�
Values are means±SD (standard deviation).
*p<0.05 when compared to the control group; 
� p<0.05 when compared to the high salt group.
FECa, Fractional excretion of calcium.
Table 2. Urinary excretion of calcium in high salt diet-induced hypercalciuric rats
Fig. 2. TRPV5 expression in high salt diet-induced hypercalciuric rats.
TRPV5 protein abundance was significantly increased in the HCTZ
group, decreased in the high salt group, and increased in the high
salt with HCTZ group when compared to the high salt group.
*p<0.05 when compared to the control group; 
� p<0.05 when com-
pared to the high salt group.
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Fig. 3. Calbindin-D28K expression in high salt diet-induced hypercalci-
uric rats. Calbindin-D28K protein abundance was significantly
increased in both high salt and high salt with HCTZ groups.
*p<0.05 when compared to the control group.
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N2 (Control) T2 (HCTZ) C (High Ca) CT (High Ca with HCTZ)
Body weight gain (g) 28.00±6.88 28.15±4.34 29.20±5.63 24.20±2.59
Urine volume (mL) 11.35±3.83 22.72±3.49* 9.97±1.95 22.38±2.84*
Serum Ca (mg/dL) 9.43±1.08 9.55±2.43 10.85±0.92 9.48±1.63
Serum Na (mM/L) 141.65±1.46 142.00±3.23 138.50±1.73 142.70±4.35
Hematocrit (%) 50.40±3.00 50.60±4.53 53.80±4.56 50.07±1.60
Values are mean±SD (standard deviation).
*p<0.05 when compared to the control group.
Table 3. Body weight gain, urine volume, hematocrit, and serum sodium concentration in high calcium diet-induced hypercalciuric rats
(n=5 in each group)Hypercalciuria induced by high calcium diet
Urinary excretion of calcium
Changes in body weight, hematocrit, and serum sodium con-
centration did not differ significantly among groups (Table 3).
Urine Ca/Cr on day 0 was not significantly different among
groups. On day 7, urine Ca/Cr was significantly increased in
the high Ca group (Fig. 5). In the high Ca with HCTZ group,
urine Ca/Cr was decreased to about 47% levels of high Ca
group (control vs. HCTZ vs. high Ca vs. high Ca with HCTZ,
0.40±0.16 vs. 0.19±0.08 vs. 2.49±0.51 vs. 1.17±0.05;
p<0.05). Urine Ca/Cr is summarized in Table 4.
Protein abundance using semiquantitative immunoblotting
Immunoblotting for TRPV5 revealed significantly decreased
band density in the high Ca group and restored band densi-
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Fig. 4. Protein abundance of sodium transporters in high salt diet-induced hypercalciuric rats. Protein abundance of NHE3 and NKCC2 was
increased in the HCTZ group, but decreased in the high salt group. NCC protein abundance increased in the HCTZ group, but was not
changed in the high salt group. SGLT1 protein abundance increased in both HCTZ group and high salt group.
*p<0.05 when compared to the control group.
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N1 (Control) T1 (HCTZ) S (High salt) ST (High salt with HCTZ)
D0 Urine Ca/Cr 0.59±0.11 0.61±0.34 0.71±0.07 0.56±0.32
D7 Urine
Ca/Cr 0.40±0.16 0.19±0.08* 2.49±0.51* 1.17±0.05*
�
FECa (%) 2.15±0.85 1.03±0.61* 12.71±3.33* 6.20±0.56*
�
Values are means±SD (standard deviation).
*p<0.05 when compared to the control group; 
� p<0.05 when compared to the high salt group.
FECa, Fractional excretion of calcium.
Table 4. Urinary excretion of calcium in high calcium diet-induced hypercalciuric ratsty in the high Ca with HCTZ group (band density [%]; con-
trol vs. HCTZ vs. high Ca vs. high Ca with HCTZ, 100±
18.92 vs. 168.04±29.83 vs. 60.06±9.31 vs. 123.77±23.90;
Fig. 6). Protein abundance of calbindin-D28K did not differ
significantly among groups (band density [%]; control vs.
HCTZ vs. high Ca vs. high Ca with HCTZ, 100±22.18
vs. 102.68±11.42 vs. 101.66±24.24 vs. 94.54±29.38;
Fig. 7). Protein abundance of NHE3, SGLT1, and NKCC2
was significantly decreased in the high Ca group and restored
in the high Ca with HCTZ group (band density: control vs.
HCTZ vs. high Ca vs. high Ca with HCTZ, NHE3 [%]; 100
±11.91 vs. 116.20±11.11 vs. 8.63±4.26 vs. 45.77±
26.29, SGLT1 [%]; 100±45.47 vs. 240.07±11.08 vs. 51.73
±8.05 vs. 95.60±25.47, NKCC2 [%]; 100±8.66 vs. 123.08
±1.56 vs. 66.05±4.72 vs. 80.16±17.66, NCC [%]; 100
±26.18 vs. 161.07±30.44 vs. 62.49±28.93 vs. 67.14±
9.93; Fig. 8).
DISCUSSION
To reveal the mechanisms of hypocalciuric effect of thiazide,
we analyzed and compared changes of TRPV5 and major
sodium transporters before and after HCTZ administration
in both normal and hypercalciuric conditions induced by diet
intervention. Regarding hypocalciuric effect of thiazide, there
has been no report examining both major calcium and sodi-
um transporters.
Protein abundance of TRPV5, NHE3, and NKCC2 was
significantly decreased in all hypercalciuric rats. Our results
imply that hypercalciuria may be caused by dysregulation of
several stages of calcium transportation in the kidneys (15).
Approximately 70% of calcium reabsorption occurs in the
proximal tubule, predominantly through paracellular path-
ways with salt and water carrying calcium from the lumen
to the interstitium by solvent drag. Approximately 20% of
filtered calcium is reabsorbed in the TAL of the loop of Henle
via both paracellular and transcellular processes. In the TAL,
the driving force for paracellular transport of calcium is pro-
vided by a lumen-positive voltage generated by the NKCC2.
The remaining approximately 10% of filtered calcium is reab-
sorbed in the distal convoluted tubule and connecting tubule;
reabsorption in these segments is predominantly mediated
by active transcellular transport under hormonal regulation
(3, 16-18). 
TRPV5 is confined to the apical domain of the epithelial
cells lining the distal part of the distal convoluted tubule and
the connecting tubule (5, 19). Other proteins involved in cal-
cium transport such as calbindin-D28K, Na+-Ca2+ exchanger
type 1, and plasma membrane Ca2+-ATPase 1b are also locat-
ed in these segments, but they are distributed in the cytoplasm
or on the basolateral membrane (5). Although TRPV6 is also
expressed in these segments, it is concentrated in the small
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Fig. 5. Urine Ca/Cr ratio on day 7 in high calcium diet-induced hyper-
calciuric rats. Urine Ca/Cr was significantly increased in the high Ca
group. In the high Ca with HCTZ group, urine Ca/Cr was decreased
to about 47% of the high Ca group.
*p<0.05 when compared to the control group; 
� p<0.05 when com-
pared to the high Ca group.
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Fig. 6. TRPV5 expression in high calcium diet-induced hypercal-
ciuric rats. TRPV5 protein abundance was significantly decreased
in the high Ca group, but restored in the high Ca with HCTZ group.
*p<0.05 when compared to the control group; 
� p<0.05 when com-
pared to the high Ca group.
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Fig. 7. Calbindin-D28K expression in high calcium diet-induced
hypercalciuric rats. Protein abundance of calbindin-D28K was not
different among groups.
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(4). Therefore, TRPV5 can be expected to have a major role
in active calcium reabsorption in the distal convoluted tubule.
Our results coincide with the basic phenomena mentioned
above showing significant decrease of TRPV5, NHE3, and
NKCC2 protein abundance in all hypercalciuric rats. Although
protein abundance of NHE3 and NKCC2 was decreased in
all hypercalciuric rats regardless of experimental protocols,
there seemed to be different underlying mechanisms. In experi-
ment 1, abundance of sodium and chloride may have result-
ed in significant decrease of NHE3 and NKCC2. On the other
hand, in experiment 2, abundant carbon dioxide released from
CaCO3may have induced alkalemic condition, and consequent-
ly facilitated bicarbonate excretion by down-regulation of
NHE3 and NKCC2 because the normovolemic condition
was maintained by providing electrolyte solution. It is already
well known that bicarbonate excretion will rise only if the
stimulus to sodium and chloride retention is removed by the
restoration of normovolemia, and acid-base balance has influ-
ence on NHE3 and NKCC2 (2). However, some reported
contradictory results about the changes of NHE3 in dietary
NaCl intake and of NKCC2 in saline loading (20, 21). Dis-
crepancy between our data and their results seemed to be caus-
ed from different experiment protocols, specifically, NaCl
amount. In our experiment 1, we loaded much more salt than
previous studies.
Changes of calbindin-D28K protein abundance differed sig-
nificantly depending on the protocols used to induce hyper-
calciuria. Calbindin-D28K protein abundance did not change
in high calcium diet-induced hypercalciuric rats, but signif-
icantly increased in high salt diet-induced hypercalciuric rats
suggesting that transporters on the luminal side may play a
more substantial role in the regulation of calcium excretion
and calbindin-D28K may not be a critical determining factor
of hypercalciuria. One previous report using calbindin-D28K
knockout mice also demonstrated that calbindin-D28K did not
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Fig. 8. Protein abundance of sodium transporters in high calcium diet-induced hypercalciuric rats. Protein abundance of NHE3, SGLT1,
NKCC2, and NCC was decreased in the high Ca group. Protein abundance of NHE3, SGLT1, and NKCC2 was increased by HCTZ in
the high Ca with HCTZ group when compared to the high Ca group.
*p<0.05 when compared to the control group; 
� p<0.05 when compared to the high Ca group.
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(22). In that study, calbindin-D28K knockout mice did not show
hypercalciuria, whereas TRPV5 knockout mice and TRPV5/
calbindin-D28K double knockout mice showed similar degrees
of hypercalciuria. Our results also imply that major transporters
participating in both active and passive calcium reabsorption
are associated with the development of hypercalciuria. Fur-
ther studies are needed to elucidate the functional correlation
between TRPV5 and calbindin-D28K after HCTZ treatment
in hypercalciuria.
Although the degree of hypercalciuria induced by high salt
diet was less severe than that by high calcium diet, high salt
diet itself caused significant hypercalciuria. The clinically harm-
ful effect of high salt diet on urinary calcium excretion was
already proposed in the 1960’s (23, 24). Borghi et al. (25)
reported that animal protein and salt increased calcium
excretion. Our results support the previous clinical observa-
tion providing a possible physiologic explanation.
In the HCTZ group, protein abundance of NHE3, SGLT1,
NKCC2, and NCC was increased. Upregulation of NCC pro-
tein abundance after chronic HCTZ treatment was previous-
ly reported (26). Protein abundance of TRPV5 was signifi-
cantly increased in the HCTZ group. Changes in protein
abundance of TRPV5 and major sodium transporters of the
PT and TAL coincide with the hypocalciuric effect of HCTZ,
and imply that both TRPV5 and sodium transporters col-
laborate reducing calcium excretion in rats fed with normal
diet after HCTZ administration.
HCTZ resulted in significant reduction of urinary calcium
excretion in all hypercalciuric rats, and the degree of hypocal-
ciuric effect was similar regardless the protocols inducing hyper-
calciuria; in the high salt with HCTZ group, urine Ca/Cr de-
creased to about 41% of the high salt group; in the high Ca
with HCTZ group, urine Ca/Cr decreased to about 47% of
the high Ca group.
Several distinct hypotheses have been proposed concerning
the hypocalciuric effect of HCTZ. Nijenhuis et al. reported
that HCTZ-induced hypocalciuria is accompanied by a decrease
in TRPV5, Na+-Ca2+ exchanger, and calbindin-D28K in rat
kidneys and that extracellular volume contraction is a criti-
cal determinant of HCTZ-induced hypocalciuria (27). Lee
et al. proposed that HCTZ induces hypocalciuria through
different mechanisms depending on volume status (28). Nijen-
huis et al. suggested that enhanced passive calcium reabsorp-
tion is more important for HCTZ-induced hypocalciuria than
active calcium reabsorption (29). In this study, the rats were
provided with drinking water containing 0.8% NaCl and
0.1% KCl to prevent volume depletion, and measured data
such as weight gain, hematocrit, and serum sodium concen-
tration showed no difference among groups, reflecting a com-
parable volume status.
Protein abundance of TRPV5 was increased by HCTZ in
all hypercalciuric rats fed with high salt or high calcium diet.
However, protein abundance of NHE3, SGLT1, and NKCC2
was increased by HCTZ in the high Ca with HCTZ group,
but was not affected by HCTZ in the high salt with HCTZ
group. Despite the different effect of HCTZ on NHE3, SGLT1,
and NKCC2 in hypercalciuric rats, HCTZ showed a similar
hypocalciuric effect in both experiments; about 50% reduction
of calcium excretion by HCTZ. This suggests that TRPV5
has a more crucial function in the regulation of calcium excre-
tion in hypercalciuric conditions. Our results are compatible
with the previous report by Hoenderop et al. (30) demonstrat-
ing the essential role of TRPV5 in calcium homeostasis using
TRPV5-null mice, and the report by Gkika et al. (22) show-
ing that the gatekeeper function of TRPV5 is the rate-limit-
ing step in active calcium reabsorption using single- and dou-
bleknockout mice lacking TRPV5 and calbindin-D28K.
In conclusion, decreased protein abundance of TRPV5,
NHE3, and NKCC2 is associated with the development of
hypercalciuria, and changes in protein abundance of TRPV5
may be related to the HCTZ-induced hypocalciuric effect in
both normal and hypercalciuric conditions. Our data suggest
that TRPV5 is a critical determinant of the hypocalciuric effect
of chronic HCTZ treatment. 
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